US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 25.150
  • -0.850-3.27%
Close Feb 28 16:00 ET
  • 26.000
  • +0.850+3.38%
Post 20:01 ET
3.16BMarket Cap-15.72P/E (TTM)

Apellis Pharmaceuticals Key Stats

Apellis Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 28, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
197.91M
212.53M
+14.61M
Beat Est.
+35.21%
+45.19%
+7.38%
EPS
-0.39
-0.29
+0.10
Beat Est.
+46.23%
+60.27%
+26.11%
Buy

Mar 1, 2025

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 210.533M--
--2025/Q1-- / 197.238M--
Feb 28, 20252024/Q4212.528M / 197.915M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 210.533M--
--2025/Q1-- / 197.238M--
Feb 28, 20252024/Q4212.528M / 197.915M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More